Efficacy and Safety of Radiotherapy Combined With Apatinib Mesylate in the Treatment of Rhabdomyosarcoma in Children

NCT03868852 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Childhood Rhabdomyosarcoma

Interventions

DRUG: Apatinib mesylate tablets
RADIATION: Three-dimensional conformal intensity modulation

Sponsor

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine